These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 3369432

  • 21. Cytogenetic survey of 117 Tunisian patients with de novo myelodysplastic syndrome.
    Sendi HS, Hichri H, Elghezal H, Gribaa M, Laatiri A, Elloumi M, Ben Lakhal R, Saad A.
    Ann Genet; 2002; 45(3):131-5. PubMed ID: 12381443
    [Abstract] [Full Text] [Related]

  • 22. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY, Wang Y, Li DP, Li ZY, Qiu TT, Xu KL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [Abstract] [Full Text] [Related]

  • 24. Complex chromosomal abnormalities in a patient with refractory anemia with excess blasts (RAEB).
    Christodoulidou F, Coleman M, Macera MJ, Verma RS.
    Cancer Genet Cytogenet; 1991 Jul 15; 54(2):229-32. PubMed ID: 1884355
    [Abstract] [Full Text] [Related]

  • 25. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M, Yamauchi H.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul 15; 52(4):800-10. PubMed ID: 2618556
    [Abstract] [Full Text] [Related]

  • 26. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans-Sabrafen J.
    Cancer Genet Cytogenet; 1992 Nov 15; 64(1):12-20. PubMed ID: 1458444
    [Abstract] [Full Text] [Related]

  • 27. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S.
    Leukemia; 1993 Apr 15; 7(4):499-508. PubMed ID: 8464227
    [Abstract] [Full Text] [Related]

  • 28. Clinical-cytogenetic correlations in myelodysplasia (preleukemia).
    Pierre RV, Catovsky D, Mufti GJ, Swansbury GJ, Mecucci C, Dewald GW, Ruutu T, Van Den Berghe H, Rowley JD, Mitelman F.
    Cancer Genet Cytogenet; 1989 Jul 15; 40(2):149-61. PubMed ID: 2766240
    [Abstract] [Full Text] [Related]

  • 29. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.
    Breccia M, Latagliata R, Carmosino I, Gentilini F, D'Elia GM, Levi A, Natalino F, Frustaci A, De Cuia MR, Alimena G.
    Acta Haematol; 2007 Jul 15; 117(4):221-5. PubMed ID: 17259693
    [Abstract] [Full Text] [Related]

  • 30. Chromosomes in myelodysplastic syndrome: structural abnormalities of chromosome 11. Czechoslovak MDS Cooperative Group.
    Musilova J, Michalova K, Jarosova M.
    Ann Genet; 1989 Jul 15; 32(1):43-6. PubMed ID: 2751248
    [Abstract] [Full Text] [Related]

  • 31. The prognostic significance of auer rods in myelodysplasia.
    Seymour JF, Estey EH.
    Br J Haematol; 1993 Sep 15; 85(1):67-76. PubMed ID: 8251411
    [Abstract] [Full Text] [Related]

  • 32. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
    Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N.
    Br J Haematol; 2006 Jan 15; 132(2):162-7. PubMed ID: 16398650
    [Abstract] [Full Text] [Related]

  • 33. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
    Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS.
    Am J Hematol; 1995 Jul 15; 49(3):194-200. PubMed ID: 7604812
    [Abstract] [Full Text] [Related]

  • 34. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH, Kantarjian HM, O'Brien S, Kornblau S, Andreeff M, Beran M, Pierce S, Keating M.
    Cytokines Mol Ther; 1995 Mar 15; 1(1):21-8. PubMed ID: 9384660
    [Abstract] [Full Text] [Related]

  • 35. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T, Menezes de Souza J, Macedo Silva ML, Tabak D, Abdelhay E.
    Leuk Res; 1998 Feb 15; 22(2):125-34. PubMed ID: 9593469
    [Abstract] [Full Text] [Related]

  • 36. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.
    Haematologica; 2006 Dec 15; 91(12):1596-604. PubMed ID: 17145595
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Serum proteomics in patients with RAEB myelodysplastic syndromes].
    Zhong LY, Liu TH, Li YQ, Geng SX, Lu ZS, Weng JY, Wu SJ, Luo CW, Du X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep 15; 29(9):1799-801. PubMed ID: 19778794
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.